We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+8.89%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.6B
AUM Growth
-$3.14B
Cap. Flow
-$4.07B
Cap. Flow %
-27.91%
Top 10 Hldgs %
20.74%
Holding
1,655
New
313
Increased
216
Reduced
349
Closed
770

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$214M
2
MDT icon
Medtronic
MDT
+$123M
3
CHTR icon
Charter Communications
CHTR
+$97.9M
4
MRK icon
Merck
MRK
+$94M
5
ZTS icon
Zoetis
ZTS
+$91.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$253M
2
BIDU icon
Baidu
BIDU
+$120M
3
STZ icon
Constellation Brands
STZ
+$110M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$104M
5
ABT icon
Abbott
ABT
+$98.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.88%
2 Technology 16.43%
3 Industrials 11.26%
4 Consumer Discretionary 9.99%
5 Financials 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.83T
$487M 3.34%
4,254,065
-821,310
-16% -$89M
ZTS icon
2
Zoetis
ZTS
$31.6B
$385M 2.64%
4,202,241
+1,034,161
+33% +$91.7M
ABMD
3
DELISTED
Abiomed Inc
ABMD
$310M 2.13%
690,160
+214,655
+45% +$84.6M
BSX icon
4
Boston Scientific
BSX
$67.5B
$282M 1.94%
7,333,396
-1,615,233
-18% -$56.4M
GPN icon
5
Global Payments
GPN
$24.4B
$275M 1.89%
2,162,102
+655,495
+44% +$78.8M
UNH icon
6
UnitedHealth
UNH
$354B
$272M 1.87%
1,022,572
+39,318
+4% +$10.2M
SPGI icon
7
S&P Global
SPGI
$130B
$271M 1.86%
1,387,773
+81,878
+6% +$16.9M
GOOGL icon
8
Alphabet (Google) Class A
GOOGL
$4.23T
$270M 1.85%
4,468,700
+3,537,400
+380% +$214M
PFE icon
9
Pfizer
PFE
$159B
$236M 1.62%
5,655,623
+1,105,422
+24% +$42.6M
CSGP icon
10
CoStar Group
CSGP
$13.1B
$231M 1.58%
5,481,940
+773,730
+16% +$33.1M
MRK icon
11
Merck
MRK
$364B
$228M 1.57%
3,368,259
+1,475,797
+78% +$94M
SEE
12
DELISTED
Sealed Air
SEE
$227M 1.56%
5,660,228
+326,156
+6% +$13.5M
DGX icon
13
Quest Diagnostics
DGX
$26.8B
$226M 1.55%
2,092,866
-565,264
-21% -$62M
DHR icon
14
Danaher
DHR
$152B
$176M 1.21%
1,830,675
+346,224
+23% +$31.5M
A icon
15
Agilent Technologies
A
$43.5B
$174M 1.2%
2,471,337
-493,983
-17% -$32.7M
CSL icon
16
Carlisle Companies
CSL
$14.1B
$172M 1.18%
1,415,107
-328,709
-19% -$40.1M
EFX icon
17
Equifax
EFX
$22.9B
$169M 1.16%
1,291,279
+403,174
+45% +$52.5M
CTAS icon
18
Cintas
CTAS
$81.9B
$166M 1.14%
3,353,780
+728,852
+28% +$37.7M
V icon
19
Visa
V
$714B
$159M 1.09%
1,060,305
+325,768
+44% +$46.3M
CI icon
20
Cigna
CI
$73.5B
$159M 1.09%
761,135
+344,859
+83% +$63.9M
VRTX icon
21
Vertex Pharmaceuticals
VRTX
$137B
$155M 1.07%
804,761
-583,039
-42% -$104M
BERY
22
DELISTED
Berry Global Group, Inc.
BERY
$154M 1.06%
3,472,557
-654,629
-16% -$28.8M
HUM icon
23
Humana
HUM
$46.9B
$151M 1.04%
445,234
+155,010
+53% +$50.4M
ROP icon
24
Roper Technologies
ROP
$41.9B
$150M 1.03%
507,364
+124,939
+33% +$36.8M
USFD icon
25
US Foods
USFD
$23.1B
$137M 0.94%
4,443,836
+981,494
+28% +$33.9M
1
2 3 4 5

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2018 Portfolio in Review

As of Q3 2018, Marshall Wace North America held 1,655 positions worth $14.6B, down 18% from $17.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Marshall Wace North America withdrew a net $4.07B in Q3 2018, closing 770 positions and reducing 349 holdings. Its most notable exit was Baidu, an estimated $120M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

Against the trend, Marshall Wace North America opened a new position in Medtronic worth $130M.

  • Marshall Wace North America's largest Q3 2018 buy was Medtronic: 1,325,878 shares worth $130M.
  • Marshall Wace North America added most to Alphabet (Google) Class A in Q3 2018, an estimated $214M increase.
  • Marshall Wace North America's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $253M.
  • Marshall Wace North America fully exited Baidu in Q3 2018, selling an estimated $120M.
  • Marshall Wace North America's ten largest holdings make up 21% of its $14.6B portfolio in Q3 2018.
  • Marshall Wace North America opened 313 new positions and closed 770 in Q3 2018.
  • Marshall Wace North America's portfolio value fell 18% quarter-over-quarter to $14.6B.

Based on Marshall Wace North America's 13F filing for Q3 2018, filed 14 Nov 2018.